Navigation Links
Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems
Date:9/13/2010

AMSTERDAM, Sept. 13 /PRNewswire/ -- An 80-year-old lung cancer patient has become the first person in The Netherlands to be treated using a new linear accelerator that can deliver precise radiotherapy more quickly than conventional systems. VU University Medical Center carried out the treatment last week, becoming only the second hospital in Europe to begin clinical treatments using TrueBeam™ from Varian Medical Systems (NYSE: VAR).

The patient received eight stereotactic body radiosurgery treatments over a two-week period using TrueBeam in combination with Varian's RapidArc® technology.

Professor Ben Slotman, the hospital's head of radiation oncology, says, "The treatment has proceeded very well. Thanks to the higher dose rate delivery capabilities of TrueBeam and the speed of RapidArc, we were able to minimize the time this patient needed on the treatment couch and really limit the opportunity for tumor motion during treatment.  

"From a clinical perspective, TrueBeam enables better integration between imaging and treatment delivery, much faster dose output using the flattening filter free mode, and a much shorter time is needed for pre-treatment setup due to the user-friendly nature of the equipment."

The hospital, a pioneer in using advanced radiotherapy techniques, now plans to use TrueBeam to treat many more cancer patients with stereotactic body radiotherapy, which involves delivering the required dose with high precision in fewer, higher dose fractions – treatment sessions – than with conventional radiotherapy.

VU University Medical Center has used RapidArc radiotherapy technology to treat over 1,000 patients since becoming one of the first hospitals in Europe to introduce the technology in 2008. RapidArc delivers a volumetric intensity-modulated radiation therapy (IMRT) treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced image-guided IMRT two to eight times faster than is possible with conventional IMRT. Since its introduction, Varian has installed more than 500 RapidArc systems in cancer centers globally.  

"We are delighted to now become only the second oncology center in Europe, after Zurich University Hospital, to treat clinically using TrueBeam," adds Prof. Slotman, who will be presenting research findings into both RapidArc and TrueBeam treatments at the European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition in Barcelona this week. "We now have cone beam CT scans and RapidArc on all six treatments machines in the department, which allows us to use the new technologies for large groups of patients."

Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, the TrueBeam platform for image-guided radiotherapy and radiosurgery as introduced in April as the first fully-integrated system designed from the ground up to treat a moving target with unprecedented speed and accuracy. A second TrueBeam system is currently being installed at VU University Medical Center and is due to enter clinical operation in November.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance
2. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
3. American Association for Respiratory Care (AARC) Joins DRIVE4COPD to Raise Awareness of Nations 4th Leading Cause of Death
4. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
5. Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide
6. Premier Members to Benefit from Full Line of Market-Leading Masimo rainbow Pulse CO-Oximetry Solutions with New Agreement
7. Clayton, Dubilier & Rice and GS Capital Partners Announce Acquisition of HGI Holdings, Inc., a Leading Medical Supplies Distributor
8. Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players
9. Leading Experts to Speak at Focused Ultrasound Symposium
10. ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
11. Get the Leading Fucoidan Supplement on the go With LIMU ORIGINAL(TM) SHOT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
Breaking Medicine Technology:
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... Middletown, PA (PRWEB) , ... February 12, 2016 , ... ... year’s event will be held in Anaheim, CA at the Anaheim Convention Center. Almost ... they can see new therapy products in action, learn more about their chosen field ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... firm announced that nominations have closed for the ISE Southeast Awards 2016. Finalists ... be announced at the ISE® Southeast Executive Forum and Awards Gala on March ...
(Date:2/12/2016)... ... 12, 2016 , ... Every winter, someone is killed, injured or loses a ... Burn Center, part of the Allegheny Health Network, has partnered with Etna Volunteer ... Heaters Need Space” campaign. , “Space Heaters Need Space” aims to bring ...
Breaking Medicine News(10 mins):